Introduction Penile prosthesis implantation (PPI) is a treatment option recommended in
clinical guidelines for erectile dysfunction (ED). However, a limited number of urologists …

Patient out-of-pocket (OOP) cost represents an access barrier to erectile dysfunction (ED)
treatment. We determined OOP cost for men with ED covered by Fee-for-Service Medicare …

Background The clinical correlation between erectile dysfunction (ED) and depression has
been revealed in cumulative studies. However, the evidence of shared mechanisms …

Introduction Prior consensus meetings have addressed the relationship between
phosphodiesterase type 5 (PDE5) inhibition and cardiac health. Given significant …

Background In 1999, 1 year after the approval of the first oral phosphodiesterase type 5
(PDE5) inhibitor for the treatment of erectile dysfunction (ED), the first Princeton Consensus …

Semaglutide was approved in June 2021 for weight loss in non-diabetic, obese patients.
While package inserts include sexual dysfunction as a side effect, no study has assessed …

We read with interest the article by Tong et al.[1], which evaluated the risk of erectile
dysfunction (ED) after urate lowering therapy (ULT) and favored allopurinol over febuxostat …

We evaluated depression-related health care resource utilization and antidepressant
prescription medication utilization among commercially insured men in the United States …

Ce premier article synthétise le point de vue du Conseil d'administration de l'Association
interdisciplinaire post-universitaire de sexologie (aius. fr) sur la thématique «Acteurs en …

Dear Editor, Based on previous case reports, a 2023 report by the UK Commission on
Human Medicines recommended increased warnings on the potential risk for sexual …